Thrombotic Thrombocytopenic Purpura after COVID-19 Vaccination: A Case Report

Hasselbach, Lisa; Voß, Andreas

doi:10.26502/acbr.50170198

Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.

Arch Clin Biomed Res

2021

DOI: 10.26502/acbr.50170198

|View full text |Cite

Thrombotic Thrombocytopenic Purpura after COVID-19 Vaccination: A Case Report

Lisa Hasselbach¹,

Andreas Voß²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further augmenting the spectrum is the therapy-related iTTP following exposure to the COVID-19 vaccine leading to either a relapse of a known iTTP in remission or a de novo iTTP due to a novel mechanism (molecular mimicry by the spike antigen and an amplified T cell and B cell response), requiring PEX and immunosuppression [8] , [9] ( Fig. 1 E).…”

mentioning

confidence: 99%

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options

Mir¹

2022

Thrombosis Research

View full text Add to dashboard Cite

mentioning

confidence: 99%

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options

Mir¹

2022

Thrombosis Research

View full text Add to dashboard Cite

Covid-19 Vaccines: Targets, Pre-Clinical Studies, Mechanisms of Action, Adrs, and Rollout in India – A Journey So Far

Gosavi

SHINDE²

2022

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Coronavirus disease 2019 pandemic has been posing a serious threat to global public health till date. This calls for the development of effective treatment protocols, and most importantly, vaccines against the pathogen. Keeping these requirements in mind, we have pooled together, across broad domains of research, accounts on the leading efforts in the development of various vaccine candidates. It is apparent from our review of various studies that the efficacy of seemingly different techniques applied together, collaborative efforts coupled with rapid, timely dissemination of results has been the key behind successful vaccine development. The availability of curated databases has also been of great advantage. Furthermore, we have summarized in this article, the side effects of the various vaccines. We hope that this review will appeal the researchers and students as well as recent entrants in these research domains and the various studies described herein will inspire and be helpful for the advancement of public health.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Thrombotic Thrombocytopenic Purpura after COVID-19 Vaccination: A Case Report

Cited by 2 publications

References 0 publications

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options

Covid-19 Vaccines: Targets, Pre-Clinical Studies, Mechanisms of Action, Adrs, and Rollout in India – A Journey So Far

Contact Info

Product

Resources

About